All changes for the tissue urinary system (132)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA880
Kidney mass gradually lost
Physiological
kidney
Human
—
—
DAA265
complement component 1, s subcomponent
Molecular
kidney
Human
C1S
24.0% Increase Gene Expression Level
DAA289
brain protein 44-like
Molecular
kidney
Human
BRP44L
9.0% Decrease Gene Expression Level
DAA287
creatine kinase, brain
Molecular
kidney
Human
CKB
10.0% Decrease Gene Expression Level
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA277
tyrosinase-related protein 1
Molecular
kidney
Human
TYRP1
21.0% Decrease Gene Expression Level
DAA274
immunoglobulin lambda variable 3-25
Molecular
kidney
Human
IGLV3-25
46.0% Increase Gene Expression Level
DAA284
immunoglobulin lambda variable 4-3
Molecular
kidney
Human
IGLV4-3
41.0% Increase Gene Expression Level
DAA261
hypothetical LOC100126583
Molecular
kidney
Human
—
43.0% Increase Gene Expression Level
DAA260
hypothetical protein LOC284214
Molecular
kidney
Human
—
53.0% Increase Gene Expression Level
DAA291
chromosome 1 open reading frame 162
Molecular
kidney
Human
C1orf162
37.0% Increase Gene Expression Level
DAA259
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
Molecular
kidney
Human
IGJ
60.0% Increase Gene Expression Level
DAA894
Interstitial fibrosis in medulla
Physiological
kidney
Human
—
—
DAA257
kininogen 1
Molecular
kidney
Human
KNG1
17.0% Decrease Gene Expression Level
DAA283
lactotransferrin
Molecular
kidney
Human
LTF
115.0% Increase Gene Expression Level
DAA270
lipoprotein lipase
Molecular
kidney
Human
LPL
17.0% Decrease Gene Expression Level
DAA290
lysozyme (renal amyloidosis)
Molecular
kidney
Human
LYZ
57.0% Increase Gene Expression Level
DAA266
matrix metallopeptidase 7 (matrilysin, uterine)
Molecular
kidney
Human
MMP7
23.0% Increase Gene Expression Level
DAA2026
Mutations in mitochondrial DNA accumulate
Physiological
heart, kidney, skeletal muscle, cerebral cortex, cerebellum
Human
—
—
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA279
nicotinamide N-methyltransferase
Molecular
kidney
Human
NNMT
40.0% Increase Gene Expression Level
DAA264
paraoxonase 3
Molecular
kidney
Human
PON3
13.0% Decrease Gene Expression Level
DAA280
FXYD domain containing ion transport regulator 2
Molecular
kidney
Human
FXYD2
5.0% Decrease Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
DAA1498
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
Molecular
kidney
Mouse
Hmgcs1
4.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA880 | Kidney mass gradually lost | Physiological | kidney | Human | — | — | |
DAA265 | complement component 1, s subcomponent | Molecular | kidney | Human | C1S | 24.0% Increase Gene Expression Level | |
DAA289 | brain protein 44-like | Molecular | kidney | Human | BRP44L | 9.0% Decrease Gene Expression Level | |
DAA287 | creatine kinase, brain | Molecular | kidney | Human | CKB | 10.0% Decrease Gene Expression Level | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA277 | tyrosinase-related protein 1 | Molecular | kidney | Human | TYRP1 | 21.0% Decrease Gene Expression Level | |
DAA274 | immunoglobulin lambda variable 3-25 | Molecular | kidney | Human | IGLV3-25 | 46.0% Increase Gene Expression Level | |
DAA284 | immunoglobulin lambda variable 4-3 | Molecular | kidney | Human | IGLV4-3 | 41.0% Increase Gene Expression Level | |
DAA261 | hypothetical LOC100126583 | Molecular | kidney | Human | — | 43.0% Increase Gene Expression Level | |
DAA260 | hypothetical protein LOC284214 | Molecular | kidney | Human | — | 53.0% Increase Gene Expression Level | |
DAA291 | chromosome 1 open reading frame 162 | Molecular | kidney | Human | C1orf162 | 37.0% Increase Gene Expression Level | |
DAA259 | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Molecular | kidney | Human | IGJ | 60.0% Increase Gene Expression Level | |
DAA894 | Interstitial fibrosis in medulla | Physiological | kidney | Human | — | — | |
DAA257 | kininogen 1 | Molecular | kidney | Human | KNG1 | 17.0% Decrease Gene Expression Level | |
DAA283 | lactotransferrin | Molecular | kidney | Human | LTF | 115.0% Increase Gene Expression Level | |
DAA270 | lipoprotein lipase | Molecular | kidney | Human | LPL | 17.0% Decrease Gene Expression Level | |
DAA290 | lysozyme (renal amyloidosis) | Molecular | kidney | Human | LYZ | 57.0% Increase Gene Expression Level | |
DAA266 | matrix metallopeptidase 7 (matrilysin, uterine) | Molecular | kidney | Human | MMP7 | 23.0% Increase Gene Expression Level | |
DAA2026 | Mutations in mitochondrial DNA accumulate | Physiological | heart, kidney, skeletal muscle, cerebral cortex, cerebellum | Human | — | — | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA279 | nicotinamide N-methyltransferase | Molecular | kidney | Human | NNMT | 40.0% Increase Gene Expression Level | |
DAA264 | paraoxonase 3 | Molecular | kidney | Human | PON3 | 13.0% Decrease Gene Expression Level | |
DAA280 | FXYD domain containing ion transport regulator 2 | Molecular | kidney | Human | FXYD2 | 5.0% Decrease Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level | |
DAA1498 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | Molecular | kidney | Mouse | Hmgcs1 | 4.0% Decrease Gene Expression Level |